Stay updated on SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.

Latest updates to the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedPhase 2 Part C was not initiated and no participants were enrolled in that cohort, with the record noting Phase 1 completion and subsequent status updates.SummaryDifference1%

- Check9 days agoChange DetectedThe page revision label updated from v3.6.5 to v3.6.6. It indicates a newer page build rather than changes to the study information.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe footer now shows Revision: v3.6.5, replacing v3.6.4. This indicates a small update to the page's document version without changing the substantive content presented.SummaryDifference0.0%

- Check44 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, signaling a minor page build. This typically reflects small fixes or refinements rather than substantive content changes.SummaryDifference0.0%

- Check66 days agoChange DetectedThe revision tag on the page was updated from v3.6.2 to v3.6.3. This appears to be a small metadata update and does not alter the trial information presented.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2. This change does not modify study details or other page content.SummaryDifference0.0%

Stay in the know with updates to SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNS-101 and Cemiplimab Combo in Solid Tumors Clinical Trial page.